Merit Medical Systems, Inc. Stock News

Small-cap stocks extended their momentum into the third quarter. We believe Rambus' evolution from a licensing and patent company into a full-fledged product company is progressing well. Shake Shack stock pulled back following quarterly results that did not meet elevated expectations.

SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced 24-month efficacy findings from the non-randomized AVG cohort of the WAVE trial. Results of the AVG cohort were presented during the Late-Breaking Clinical Trials session at the annual VIVA Foundation3 Venous Endovascular Interventional Stra...

Merit Medical Systems, Inc. ( MMSI ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Martha Aronson - President, CEO & Director Brian Lloyd - Chief Legal Officer & Corporate Secretary Raul Parra - CFO & Treasurer Conference Call Participants Jason Bednar - Piper Sandler & Co., Research Division Lilia-Celine Lozada - JPMorgan Chase & Co, Research Division Jayson Bedford -...

Transaction supports PENTAX Medical's strategic focus on core flexible reusable endoscopy MONTVALE, N.J. , Oct. 15, 2025 /PRNewswire/ -- PENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, for the acquisition of the C2 Cr...

SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans to hold its investor conference call on the same d...

SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care

Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere's consistent, predictable, and effective clinical results. Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere's consistent, predictable, and effective clinical results.

Merit Medical has faced near-term headwinds from tariffs and a Wrapsody reimbursement error, but core operations remain fundamentally strong. Wrapsody's reimbursement setback is a risk, but resolution is likely by the end of 2025, preserving the long-term growth story. New CEO Martha Aronson's impact is yet to be seen, but the company appears committed to its M&A-driven strategy and operational...